PARLIAMENTARY WRITTEN QUESTION
Mental Health Services: Mothers (12 July 2022)

Prescribing clinicians should always satisfy themselves that the medicines they consider appropriate for patients can be safely prescribed. This prescribing decision and any monitoring activity should be discussed and agreed with the patient. Clinicians are expected to take account of appropriate local and national guidance and are accountable for their prescribing decisions, professionally and to service commissioners.

The Medicines and Healthcare products Regulatory Agency (MHRA) continually monitors the safety of psychotropic medications, including use in new mothers, through the assessment of data received through the Yellow Card Scheme and discussion of cases at multidisciplinary meetings.